105 related articles for article (PubMed ID: 10826362)
21. Thioguanine versus mercaptopurine in childhood ALL.
Stanulla M; Schünemann HJ
Lancet; 2006 Oct; 368(9544):1304-6. PubMed ID: 17046444
[No Abstract] [Full Text] [Related]
22. Thiopurines best practice.
Friedman A
J Gastroenterol Hepatol; 2016 Jun; 31 Suppl 1():6-7. PubMed ID: 26990458
[No Abstract] [Full Text] [Related]
23. Nuclear winter.
Lesesve JF; Mansuy L
Transfusion; 2005 Sep; 45(9):1403. PubMed ID: 16131370
[No Abstract] [Full Text] [Related]
24. Do minor differences in primary therapy influence rescue-ability after relapse in childhood ALL?
Zwaan CM; Veerman AJ
Pediatr Blood Cancer; 2005 Jul; 45(1):2-4. PubMed ID: 15706584
[No Abstract] [Full Text] [Related]
25. 6-mercaptopurine: efficacy and bone marrow toxicity in childhood acute lymphoblastic leukemia. Association with low (thio)purine enzyme activity.
De Abreu RA; Lambooy LH; Ahment K; Brouwer C; Keizer-Garritsen JJ; Bokkerink JP; Trijbels FJ
Adv Exp Med Biol; 2000; 486():271-5. PubMed ID: 11783498
[No Abstract] [Full Text] [Related]
26. Treatment adherence and 6-mercaptopurine metabolites.
Gaynon PS
Pediatr Blood Cancer; 2006 Feb; 46(2):120-1. PubMed ID: 16200555
[No Abstract] [Full Text] [Related]
27. Severe hypoglycemic seizures in a child receiving 6-mercaptopurine.
El-Bitar MK; Muwakkit SA; Dabbagh O
J Pediatr Hematol Oncol; 2011 Mar; 33(2):e75-6. PubMed ID: 21343747
[TBL] [Abstract][Full Text] [Related]
28. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
[TBL] [Abstract][Full Text] [Related]
29. Next steps on the thiopurine methyltransferase 6-thioguanine nucleotide pathway.
Colletti RB
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):282-3. PubMed ID: 16954947
[No Abstract] [Full Text] [Related]
30. The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia.
Melachuri S; Gandrud L; Bostrom B
Pediatr Blood Cancer; 2014 Jun; 61(6):1003-6. PubMed ID: 24415675
[TBL] [Abstract][Full Text] [Related]
31. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M
JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872
[TBL] [Abstract][Full Text] [Related]
32. [Thiopurine treatment. Significance of pharmacogenetic polymorphism].
Schmiegelow K; Hertz H
Ugeskr Laeger; 1998 Feb; 160(8):1189-91. PubMed ID: 9492634
[No Abstract] [Full Text] [Related]
33. Should thiopurine methyltransferase (TPMT) activity be determined before prescribing azathioprine, mercaptopurine, or thioguanine?
DiPiero J; Teng K; Hicks JK
Cleve Clin J Med; 2015 Jul; 82(7):409-13. PubMed ID: 26185939
[No Abstract] [Full Text] [Related]
34. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
35. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine.
Wan Rosalina WR; Teh LK; Mohamad N; Nasir A; Yusoff R; Baba AA; Salleh MZ
J Clin Pharm Ther; 2012 Apr; 37(2):237-41. PubMed ID: 21545474
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia.
Ando M; Ando Y; Hasegawa Y; Sekido Y; Shimokata K; Horibe K
Pharmacogenetics; 2001 Apr; 11(3):269-73. PubMed ID: 11337943
[No Abstract] [Full Text] [Related]
37. Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism.
Brackett J; Schafer ES; Leung DH; Bernhardt MB
Pediatr Blood Cancer; 2014 Jun; 61(6):1114-7. PubMed ID: 24376133
[TBL] [Abstract][Full Text] [Related]
38. Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?
Fakhoury M; Andreu-Gallien J; Mahr A; Medard Y; Azougagh S; Vilmer E; Jacqz-Aigrain E
J Clin Pharm Ther; 2007 Dec; 32(6):633-9. PubMed ID: 18021342
[TBL] [Abstract][Full Text] [Related]
39. Incorporation of 6-thioguanine nucleotides into DNA during maintenance therapy of childhood acute lymphoblastic leukemia-the influence of thiopurine methyltransferase genotypes.
Ebbesen MS; Nersting J; Jacobsen JH; Frandsen TL; Vettenranta K; Abramsson J; Wesenberg F; Schmiegelow K
J Clin Pharmacol; 2013 Jun; 53(6):670-4. PubMed ID: 23585236
[No Abstract] [Full Text] [Related]
40. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
